TCWM
VIVO

Total Clarity Wealth Management’s Meridian Bioscience Inc VIVO Stock Holding History

Total Clarity Wealth Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-34
Closed -$1K – 1046
2022
Q2 		$1K Buy
+34
New +$920 ﹤0.01% 1008
2022
Q1 		– Sell
-500
Closed -$10K – 989
2021
Q4 		$10K Hold
500
– – ﹤0.01% 709
2021
Q3 		$10K Buy
+500
New +$9.97K ﹤0.01% 690
2021
Q2 		– Sell
-500
Closed -$13K – 812
2021
Q1 		$13K Buy
+500
New +$11.9K 0.01% 521

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Total Clarity Wealth Management's VIVO Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 34 shares — an estimated $1K sold.

Total Clarity Wealth Management first reported a position in VIVO in Q1 2021 and held it in 4 quarters. The position peaked at $13K in Q1 2021. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 34 Meridian Bioscience Inc shares in Q3 2022, an estimated $1K.
  • Total Clarity Wealth Management first reported a position in Meridian Bioscience Inc in Q1 2021 and held it in 4 quarters.
  • Total Clarity Wealth Management's Meridian Bioscience Inc position peaked at $13K in Q1 2021.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.